Springer International Publishing, 2016. — 228 p. — ISBN: 978-3-319-24221-7, 978-3-319-24223-1. This, the first of two volumes on personalized medicine in lung cancer, touches on the core issues related to the understanding of lung cancer—statistics and epidemiology of lung cancer—along with the incidence of lung cancer in non-smokers. A major focus of this volume is the state...
Springer, 2015. — 65 p. — (Springer Briefs in Molecular Science). — ISBN: 978-81-322-2174-6, 978-81-322-2175-3. This brief provides an insight into the present scenario of the role of nanotechnology in the diagnosis and treatment of lung cancer at an early stage. Currently, lung cancer is the subject of major concern owing to the very high mortality rate throughout the world....
InTech, 2012. — 129 p. — ISBN: 978-953-51-0901-3 This book brings together the knowledge of eminent experts in the field of malignant mesothelioma, a highly invasive tumor of mesothelium that is the protective lining covering several body cavities. Malignant mesothelioma shows extremely poor progression and is refractory to almost any kind of therapy putting considerable...
Springer New York, 2012. — 216 p. As with other books in the Molecular Pathology Library Series, Molecular Pathology of Lung Cancer bridges the gap between the molecular specialist and the clinical practitioner, including the surgical pathologist who now has a key role in decisions regarding molecular targeted therapy for lung cancer. Molecular Pathology of Lung Cancer provides...
Cham, Switzerland: Adis, 2015. — 67 p. — ISBN: 978-3-319-20740-7, 978-3-319-20741-4. A concise, practical handbook on treatment resistance in lung cancer Provides oncologists and other healthcare workers involved in the diagnosis, treatment and management of patients with an up-to-date review of the background and advances in the field Easily accessible text, tables and images...
Cham: Springer International Publishing, 2019. — 341 p. This book offers an updated review of malignant mesothelioma, including the latest advances in our understanding of its genetic control and molecular biology, as well as pre-clinical and clinical research. It also presents state-of-the-art diagnostic approaches and therapeutic options, and an open discussion on the future...
Springer, 2021. — 264 p. — ISBN 978-3-030-74027-6. Lung cancer has seen a paradigm shift in disease treatment over the past few years, with major changes in the therapeutic drugs now available as well as in the overall management approach. For targeted and immunotherapeutic approaches, understanding the biology of acquired resistance is a key strategy that has yielded...
Springer, 2021. — 264 p. — ISBN 978-3-030-74027-6. Lung cancer has seen a paradigm shift in disease treatment over the past few years, with major changes in the therapeutic drugs now available as well as in the overall management approach. For targeted and immunotherapeutic approaches, understanding the biology of acquired resistance is a key strategy that has yielded...
Cambridge University Press, 2007. — 179 p. Despite the world-wide drive to increase awareness of the risks of smoking, lung cancer remains a global problem. A multidisciplinary team approach is now considered the most effective way to manage lung cancer. Imaging plays a central role in this multidisciplinary approach; this is reflected in the present volume. Individual chapters...
European Respiratory Society, 2015. — 286 p. — (ERS Monographs). — ISBN: 978-1-84984-061-3. The GLOBOCAN project (http://www.globocan.iarc.fr) is a comprehensive cancer surveillance database managed by the International Association of Cancer Registries (IACR) and supported by the World Health Organization (WHO). The project aims to provide up-to-date estimates of the incidence,...
New York: Springer, 2015. — 212 p. — ISBN: 978-1-4939-2723-4, 978-1-4939-2724-1. Presents the inflammatory tumor microenvironment in lung cancer Explores inflammation and how it affects epigenetic events in lung cancer Discusses the connection between chronic overexpression and deregulation of inflammatory mediators with lung cancer initiation and progression In recent years...
Springer, 2003. — 329 p. Lung cancer remains the leading cause of cancer-related death in men, and in women, it has surpassed even breast cancer. According to the American Cancer Society, in 2001, there will be about 169,500 new cases of lung cancer in the United States: 90,700 among men and 78,800 among women. Lung Cancer is the second installment in the M. D. Anderson Cancer...
Nova Science, 2013. — 355 p. Lung cancer is the leading cause of cancer related death in both men and women worldwide. The impact of this devastating disease on society is phenomenal with patient outcomes only marginally improving over the past four decades and the cost of treatment constantly rising. However, recent technological advances in how we diagnose cancer and the...
Academic Press, 2019. — 176 p. — ISBN: 978-0-12-812724-7. This book is a practical book developed to assist clinicians, pathologist and molecular biologist in the management of malignant pleural mesothelioma (MPM). MPM represents a challenge in terms of diagnosis, staging and treatment, and to date, the optimal management of MPM patients has not yet been clearly defined – and...
2nd edition. — Informa Healthcare, 2008. — 364 p. Textbook of Lung Cancer, 2nd edition, published in association with the European Society of Medical Oncology, is a comprehensive and multidisciplinary text, which examines all aspects of this disease, with contributions from a multinational team of authors on etiology, epidemiology, molecular biology, pathology, smoking,...
Springer, 1990. — xi, 58 p. — (Europe Against Cancer. European Commission Series for General Practitioners). The "Europe against Cancer" programme has, from its inception, emphasised the key role which general practitioners must play in the actions necessary to achieve its aim of reduc ing the incidence and the mortality from cancer in the European Community. General...
Nova Science, 2015. — 300 p. This encyclopedia presents important research on lung cancer. Some of the topics discussed herein include therapeutic antibodies in non-small cell lung cancer; radiation therapy; epigenetics; paraneoplastic syndromes associated with lung cancer; palliative radiotherapy treatments; bone and lung metastases; and asymptomatic presentation of lung and bone...
Elsevier, 2019. — 180 p. — ISBN: 978-0-323-55433-6. Get a quick, expert overview of the latest treatment and management approaches for adenocarcinoma of the lung, including novel therapeutics in immunotherapy and targeted therapies. This practical title, edited by Dr. Leora Horn, offers succinct coverage of clinically-focused topics and guidelines, making it an ideal resource...
Wiley, 2009. — 65 p. Lung Cancer is the most common cause of cancer death and cancer symptoms. The ABC of Lung Cancer is a much needed reference for those treating and caring for patients with lung cancer such as primary care doctors, specialist cancer nurses, junior doctors, nurses, physiotherapists, radiographers and other health care professionals. This new title in the ABC...
Proceedings of a Workshop. — National Academies Press, 2016. — 106 p. Lung cancer is the leading cause of cancer-related death in the United States; each year, more people die from lung cancer than from colon, breast, and prostate cancers combined. There has been a push to develop and implement screening strategies for the early detection of lung cancer. The National Lung...
Springer Science & Business Media, 2005. — 521 p. Although decades of laboratory and clinical research have led to incremental improvement in treatment outcome, lung cancer remains one of the most deadly diseases. This volume is unique in being devoted solely to the radiation oncology of lung cancer, and will be of great value to all who are involved in the diagnosis and treatment...
2nd edition. — Springer, 2011. — 824 p. — (Radiation Oncology) — ISBN: 978-3-642-19924-0 Although decades of laboratory and clinical research have led to incremental improvement in treatment outcome, lung cancer remains one of the most deadly diseases. In the second, completely updated edition of this comprehensive book, many of the world’s leading lung cancer specialists...
2nd edition. — Springer, 2011. — 3359 p. — (Radiation Oncology) — ISBN: 978-3-642-19925-7 Although decades of laboratory and clinical research have led to incremental improvement in treatment outcome, lung cancer remains one of the most deadly diseases. In the second, completely updated edition of this comprehensive book, many of the world’s leading lung cancer specialists...
Springer Publishing Company, 2016. — 370 p. Handbook of Lung Cancer and Other Thoracic Malignancies is a practical guide to management of lung cancer and other cancers of the thoracic cavity. Edited by a multidisciplinary team of cancer specialists from leading institutions, the book is an essential day-to-day reference for evidence-based care in thoracic oncology. This...
Springer, 2015. — 79 p. — ISBN: 978-981-4585-07-1. With an alarming toll of rising deaths every year, lung cancer has emerged out as major issue of concern worldwide. Lots of research on the genetic and hereditary aspects have been pursued. This book presents a comprehensive study on the molecular analysis involving in vitro as well as bioinformatics approach. Patients’ samples...
Springer New York, 2009. — 409 p. Lung cancer is the leading cause of cancer-related mortality. Metastatic lung cancer is responsible for more than ninety percent of lung cancer related deaths. However, relatively little progress has been made in understanding the process of lung cancer metastasis. The two main aims of this book are a) to introduce clinical aspects to basic...
McGraw-Hill Education / Medical, 2021. — 711 p. — ISBN 978-1-26-013620-3. Lung cancer remains the leading cause of cancer deaths worldwide, attributed mostly to environmental and behavioral factors. However, a diagnosis of lung cancer no longer means inevitable death. The new standards of care and a greater understanding of the etiology and biology of the disease has led to...
McGraw-Hill Education / Medical, 2021. — 1267 p. — ISBN 978-1-26-013621-0. Lung cancer remains the leading cause of cancer deaths worldwide, attributed mostly to environmental and behavioral factors. However, a diagnosis of lung cancer no longer means inevitable death. The new standards of care and a greater understanding of the etiology and biology of the disease has led to...
Springer, 2023. — 213 p. — ISBN 978-981-99-0142-5. This book aims to provide readers practical information on the procedure of segmentectomy for early-stage lung cancer with the use of 3D reconstruction technology. The first chapters mainly focus on the basic knowledge of lung segmentectomy, such as its history, anatomy, indications and 3D reconstruction. In the following...
Springer, 2023. — 213 p. — ISBN 978-981-99-0143-2. This book aims to provide readers practical information on the procedure of segmentectomy for early-stage lung cancer with the use of 3D reconstruction technology. The first chapters mainly focus on the basic knowledge of lung segmentectomy, such as its history, anatomy, indications and 3D reconstruction. In the following...
Nova Science Publishers, 2009. — 250 p. — ISBN: 978-1-60741-787-3. Small cell carcinoma is a type of cancer that almost always effects the lungs. Small cell carcinoma is almost always caused by smoking, but exposure to large amounts of asbestos is also a risk factor. Small cell carcinoma usually effects men more than women and while not a common type of lung cancer, is...
London: Academic Press, 2022. — 288 p. Role of Tumor Microenvironment in Breast Cancer and Targeted Therapies discusses the current understanding of breast cancer tumor microenvironment components, their role in tumorigenicity and the development of therapeutic resistance, along with updates on recent advances. Contributors Preface Introduction to various types of cancers...
Bentham Books, 2020. — 351 p. — ISBN 978-981-14-5954-2. Perspectives in Lung Cancer compiles basic and advanced topics on lung cancer pathology and treatment in a single volume. Chapters introduce the reader to chest and lung anatomy followed by the biology of lung cancer. Subsequent chapters delve into diagnostic methods for lung cancer while progressing into treatment...
Springer, 2021. — 336 p. — (Respiratory Disease Series: Diagnostic Tools and Disease Managements). — ISBN 978-981-15-9157-0. This book provides essential information on recent advances in molecular genetics, epidemiology, translational research, and the latest results of clinical trials on mesothelioma. Significant progress has been made in understanding mesothelioma biology,...
Springer, 2021. — 867 p. — (Respiratory Disease Series: Diagnostic Tools and Disease Managements). — ISBN 978-981-15-9158-7. This book provides essential information on recent advances in molecular genetics, epidemiology, translational research, and the latest results of clinical trials on mesothelioma. Significant progress has been made in understanding mesothelioma biology,...
Springer, 2012. — 264 p. — ISBN: 978-4431541431. The book “Illustrated Anatomical Segmentectomy for Lung Cancer” provides readers a detailed explanation of segmentectomy with numerous easy-to-understand color illustrations showing the precise segmental anatomies for each pattern of the procedure. To better illustrate an accurate anatomical segmentectomy, the text shows details...
ITexLi, 2021. — 198 p. — ISBN 1789855764 9781789855760 1789856388 9781789856385. This book comprehensively reviews the evidence that has driven personalized medicine, based on a variety of multidisciplinary perspectives by international lung cancer experts. Lung cancer continues to be the leading cause of cancer mortality worldwide among both men and women. Recent advances in...
Thieme, 2018. — 118 p. — ISBN: 9781626235137. Lung cancer is the leading cause of cancer-related death among men and women in the U.S. and worldwide. For many decades, lung cancer was the sole cancer among the deadly four without an evidence-based screening method for decreasing mortality. This changed in November 2011, when findings from the National Lung Cancer Screening...
Thieme, 2018. — 118 p. — ISBN: 9781626235137. Lung cancer is the leading cause of cancer-related death among men and women in the U.S. and worldwide. For many decades, lung cancer was the sole cancer among the deadly four without an evidence-based screening method for decreasing mortality. This changed in November 2011, when findings from the National Lung Cancer Screening...
2nd Edition. — Elsevier, 2018. — 896 p. — ISBN: 978-0-323-52357-8. Global experts, in conjunction with the International Association for the Study of Lung Cancer, bring you up to date with today’s best approaches to lung cancer diagnosis, treatment, and follow-up. IASLC Thoracic Oncology, 2nd Edition, keeps you abreast of the entire scope of this fast-changing field, from...
4th ed. — Lippincott, Willams and Wilkins, 2010. — 1040 p. Thoroughly revised and updated, this Fourth Edition is the most comprehensive, current reference on lung cancer, with contributions from the world's foremost surgeons, radiation oncologists, medical oncologists, pulmonologists, and basic scientists. Coverage includes complete information on combined modality treatments for...
Springer International Publishing, 2015. — 255 p. — ISBN: 978-3-319-06061-3, 978-3-319-06062-0. This book provides an up-to-date review of current management techniques for Non-Small Cell Lung Cancer. It addresses all of the latest issues that have been raised by the discovery of oncogenic drivers and the improvement of diagnosis and therapeutic methods, including new...
Springer International Publishing, 2016. — 87 p. — (Advances in Experimental Medicine and Biology 911). — ISBN: 978-3-319-35097-4, 978-3-319-35098-1. Genotyping-based lung cancer diagnosisThe potential to deliver big benefits to patients. Keeping up-to-date with current progress in clinical practice and research. The book series Neuroscience and Respiration presents...
Springer International Publishing, 2015. — 71 p. — (Advances in Experimental Medicine and Biology 833). — ISBN: 978-3-319-09751-0, 978-3-319-09752-7. Lung cancer and autoimmune diseases are complex entities in that they involve gene disturbance, gene polymorphism, and impaired gene repair mechanisms. The volume focuses on altered gene expression in tumor processes and in...
Springer International Publishing Switzerland, 2015. — 73 p. — ISBN10: 3319169211 The book blends basic and clinical research on respiratory carcinogensis. The contributions tackle a variety of respiratory-related cancers, notably non-small cell lung carcinoma, pleural mesothelioma, mediastinal tumors, or larynx cancer. The focus is on the search for novel molecular markers,...
2nd edition. — Rx Press North Fort Myers, 2016. — 188 p. — (International Association for the Study of Lung Cancer) — ISBN: 978-0-9832958-6-0 The IASLC Staging Manual in Thoracic Oncology (2nd Edition) includes 8th Edition Tumor, Node, and Metastasis Classification (TNM) information for Lung Cancer, Plural Mesothelioma, Thymic Malignancies, and Carcinoma of the Oesophagus and...
Springer Science & Business Media, 2013. — 194 p. While specialists often guide the care to lung cancer patients, it is often a general radiologist who is left to interpret studies that impact patient care and management. Lung Cancer Imaging provides a comprehensive guide to the diagnosis, staging and overview of the management of lung cancer relevant to practicing radiologists...
Springer International Publishing, 2016. — 322 p. — (Cancer Treatment and Research 170). — ISBN: 978-3-319-40387-8, 978-3-319-40389-2. This book describes the molecular mechanisms of lung cancer development and progression that determine therapeutic interventions in the era of genomics, when the rapid evolution in lung cancer diagnosis and treatment necessitates critical review...
Associate editors: Anne S. Tsao, Joe Y. Chang, Shanda H. Blackmon. — 4th edition. — Wiley-Blackwell, 2014. — 633 p. The best and most concise single source for state-of-the-art diagnosis and treatment of lung cancer –newly revised, updated, and expanded. Lung cancer has long been the number-one cause of death from cancer every year and the third most frequently diagnosed after...
Springer, 2006. — 670 p. — ISBN: 978-3540310396 The purpose of the textbook, Tumors of the Chest: Biology, Diagnosis and Management, is to meticulously depict all aspects of chest tumors in a comprehensive volume format that encompasses their biology, clinical presentation and management. Lung cancer and chest malignancies demand complicated therapeutical procedures without a...
Springer, 2017. — 321 p. — ISBN: 978-981-10-2000-1. This book discusses the latest molecular targeted therapy of lung cancer including its evaluation and future directions. It clearly illustrates the initial dramatic effectiveness of molecular targeted therapy, recurrence of the disease, overcoming the wide variety of resistance mechanisms using new-generation molecular...
Springer, 2011. — 206 p. — (Recent Results in Cancer Research) — ISBN: 978-3-642-10861-7 Malignant mesothelioma is an aggressive and fatal neoplasm of serous membranes. The pathogenesis of malignant mesothelioma is clearly linked to incorporated asbestos fibers. Owing to the late banning of asbestos use in industrial nations and the continuing mining and consumption of asbestos...
Springer, 2017. — 403 p. — (Current Cancer Research) — ISBN: 978-3-319-53558-6 This volume is comprised of a multidisciplinary assessment of the interplay between asbestos and cancer as well as new research about the biology and treatment of malignant mesothelioma. Chapters on the various types of asbestos and other mineral fibers, epidemiology, history and future of...
New York: Demos Medical Publishing, 2016. — 333 p. Handbook of Breast Cancer and Related Breast Diseaseis a practical guide to the management of patients with breast malignancies and related non-neoplastic lesions. Written and edited by leading experts, this handbook focuses on the application of conventional and novel treatment strategies to the care of patients with nonmalignant...
ITexLi, 2019. — 190 p. — ISBN 1789843502 9781789843507 1789843499 9781789843491 1838816399 9781838816391. The aim of this book is to provide an exciting read on strategies in the diagnosis and therapy of lung cancer. Among the deadliest type of cancers, lung cancer faces several challenges in diagnosis and treatment: late diagnosis and misdiagnosis, inadequate tumor sampling,...
Springer, 2018. — 430 p. This book discusses major issues and advances in the diagnosis and treatment of incidentally detected early-stage lung cancer (ESLC). In Part I, pathology and radiology experts comprehensively review the state-of-the-art advances in individual research fields, and offer an update on the cross-sectional anatomy of the lung and post-processing techniques for...
Учебное пособие. - Петрозаводск: ПетрГУ, 1999. - 74 с.
В пособии изложены вопросы клинической анатомии легких, знание которых необходимо в диагностике и лечении легочных заболеваний. Приведены данные об этиологии, патогенезе, клиническом течении рака легкого.
Содержание:
Клиническая анатомия лёгких.
Эпидемиология рака лёгкого.
Классификация рака лёгкого.
Диагностика рака...
М.: Литтерра, 2005. - 128 с. Опыт клинической практики. Книга «Консервативное лечение рака легкого», подготовленная ведущими специалистами НИИ клинической онкологии Российского онкологического научного центра им. Н. Н. Блохина РАМН, посвящена проблеме консервативного лечения неоперабельных форм рака легкого. В сжатой форме расставлены ключевые моменты эпидемиологии,...
М.: Литтерра, 2005. — 128 с. Опыт клинической практики. Книга «Консервативное лечение рака легкого», подготовленная ведущими специалистами НИИ клинической онкологии Российского онкологического научного центра им. Н. Н. Блохина РАМН, посвящена проблеме консервативного лечения неоперабельных форм рака легкого. В сжатой форме расставлены ключевые моменты эпидемиологии,...
Нижний Новгород.: НГМА, 2000. - 100 с. ISBN: 57032-0332-5. В книге освещаются современные проблемы диагностики и хирургического лечения распространенного рака легкого. Особое внимание уделяется выбору оперативного вмешательства в поздних стадиях заболевания. Подробно излагается техника расширенных, комбинированных, реконструктивно-пластических операций, а также операций при...
СПб.: СпецЛит, 2008. — 290 с. — ISBN: 978-5-299-00368-0.
В пособии для врачей даны сведения об этиологии, клинике, диагностике и лечении рака легкого. Впервые освещены вопросы медикосоциальной экспертизы и реабилитации больных раком легкого.
Предназначено для врачей общей практики, хирургов-интернов, клинических ординаторов и онкологов, специалистов бюро медико-социальной...
Москва: Российская академия наук, 2023. — 194 с. В монографии проанализированы данные литературы об этиологии, эпидемиологии и патогенезе рака легкого. Обобщен мировой опыт лечения рака легкого (хирургическое лечение, лучевая и химиотерапия, иммунобиологические препараты, иммунотерапия). Авторы озвучили нерешенные проблемы диагностики и лечения злокачественных опухолей, в том...
Учебно-методическое пособие. — Гомель: ГомГМУ, 2011. — 32 с. — ISBN: 978-985-506-353-8. В учебно-методическом пособии рассматриваются вопросы эпидемиологии, этиопатогенеза, клиники, диагностики и лечения злокачественных новообразований легкого. Предназначено для студентов старших курсов высших медицинских вузов, врачей-стажеров, клинических ординаторов, практических врачей....
Карманный справочник. — Москва: Практическая Медицина, 2009. — 196 с. Книга «Рак легкого» входит в серию руководств Dana-Farber Cancer Institute. Она представляет собой полноцветный карманный атлас, в котором наряду с наглядными иллюстрациями содержится информация о распространенности, эпидемиологии, этиологии, гистопатологии и клинических проявлениях данного заболевания....
European Society for Medical Oncology (ESMO), 2019. — 65 с. Данное пособие подготовлено для того, чтобы помочь вам, членам вашей семьи, вашим друзьям и коллегам лучше понять, что такое немелкоклеточный рак легкого (НМРЛ) и как он лечится. Настоящее пособие содержит информацию о различных подтипах НМРЛ, о причинах его возникновения, возможностях диагностики, лечения, а также о...
Гомель: ГомГМУ, 2017. — 24 с. — ISBN: 978-985-506-946-2. В пособии изложены основные сведения об этиологии, клинике, диагностике, лечении, профилактике и прогнозе рака легкого и гортани. Приведена TNM-классификация. Пособие соответствует учебной программе по онкологии. Предназначено для студентов 5 и 6 курсов факультета по подготовке специалистов для зарубежных стран...
Учебное пособие. — Омск: Изд-во Центра МО и ИТ ОмГМА, 2008. — 255 с. Онкологические заболевания органов грудной полости представляют собой чрезвычайно сложную, многогранную проблему теоретической и клинической онкологии. Внимание к этой проблеме в последнее время усиливается в связи с имеющейся тенденцией роста онкологической заболеваемости данных локализаций как в масштабах...
Учебное пособие для врачей. — Саратов: Саратовский государственный медицинский университет им. В.И. Разумовского, 2017. — 268 с. Учебное пособие посвящено одной из самых актуальных проблем онкологии — раку легкого. В нем представлены современные данные, касающиеся статистики, эпидемиологии, факторов риска и скрининга рака легкого. Рассмотрены вопросы биологических особенностей...
М.: ГЭОТАР МЕДИЦИНА, 2000. - 600 С.: ил. (Высокие технологии в медицине). В практическом руководстве "Клиническая онкопульмонология" последовательно и всесторонне изложено современное состояние проблемы диагностики и лечения практически всех злокачественных (рак, саркома, лимфома, карциноид и др. ), доброкачественных и метастатических опухолей легких. Практическое руководство...
2-е изд. — Ленинград: Государственное издательство медицинской литературы, 1962. — 61 с. В книге освещены вопросы диагностики и лечения рака легкого. На основании обобщения большого личного опыта и литературных источников подробно изложены данное об этиологии заболевания, о нарастающей его частоте, показана роль курения в его возникновении. Много внимания уделено распознаванию...
2-е изд. — Ленинград: Государственное издательство медицинской литературы, 1962. — 61 с. В книге освещены вопросы диагностики и лечения рака легкого. На основании обобщения большого личного опыта и литературных источников подробно изложены данное об этиологии заболевания, о нарастающей его частоте, показана роль курения в его возникновении. Много внимания уделено распознаванию...
Руководство для пациентов. — National Comprehensive Cancer Network, 2019. — 56 с. Общие сведения о раке легкого. Составление плана лечения. Справочник по методам лечения. Принятие решений о лечении. Пояснение терминов. Указатель.
Руководство для пациентов. — National Comprehensive Cancer Network, 2019. — 60 с. Общие сведения о раке легкого. Оценка узелков в легких. Составление плана лечения. Справочник по методам лечения. Принятие решений о лечении. Пояснение терминов. Указатель.
Комментарии